Skip to main content

Table 2 Gene editing for EV engineering

From: Recent advances in extracellular vesicle engineering and its applications to regenerative medicine

No.

Engineered materials

Method

Targeting cell

Ref.

1

PDGFR-RVG, hnRNPA2B1expressed/mirSilencer

lentivirus

HEK293T

[51]

2

RVG/BDNF

lentivirus

HEK293T

[52]

3

SERPINA5 protein

lentivirus

HEK293

[57]

4

Serpin protein

lentivirus

HEK293

[58]

5

miR-146a

lentivirus

PMSC

[56]

6

miR-214-3p

lentivirus

UCMSC

[55]

7

miR-133-3p

lentivirus

UCMSC

[54]

8

Tat protein

Lipofectamine

HEK293T

[59]

9

Ldlr mRNA

Lipofectamine

HEK293T

[60]

10

Protein drug (srIkB)

Effectene Transfection Reagent

HEK293T

[61]

11

Protein drug (srIkB)

Effectene Transfection Reagent

HEK293T

[62]

12

Protein drug (srIkB)

Effectene Transfection Reagent

HEK293T

[63]